key: cord-0755109-ouyfzylw
authors: Patil, Rajesh; Chikhale, Rupesh; Khanal, Pukar; Gurav, Nilambari; Ayyanar, Muniappan; Sinha, Saurabh; Prasad, Satyendra; Dey, Yadu Nandan; Wanjari, Manish; Gurav, Shailendra S.
title: Computational and Network Pharmacology Analysis of Bioflavonoids as Possible Natural Antiviral Compounds in Covid-19
date: 2020-12-23
journal: Inform Med Unlocked
DOI: 10.1016/j.imu.2020.100504
sha: e8eea208ea5ffdb4a197548ae5f645c694ce32eb
doc_id: 755109
cord_uid: ouyfzylw

Bioflavonoids are the largest group of plant-derived polyphenolic compounds with diverse biological potential and have also been proven efficacious in the treatment of Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). The present investigation validates molecular docking, simulation, and MM-PBSA studies of fifteen bioactive bioflavonoids derived from plants as a plausible potential antiviral in the treatment of COVID-19. Molecular docking studies for 15 flavonoids on the three SARS CoV-2 proteins, non-structural protein-15 Endoribonuclease (NSP15), the receptor-binding domain of spike protein (RBD of S protein), and main protease (M(pro)/3CL(pro)) were performed and selected protein-ligand complexes were subjected to Molecular Dynamics simulations. The molecular dynamics trajectories were subjected to free energy calculation by the MM-PBSA method. All flavonoids were further assessed for their effectiveness as adjuvant therapy by network pharmacology analysis on the target proteins. The network pharmacology analysis suggests the involvement of selected bioflavonoids in the modulation of multiple signaling pathways like p53, FoxO, MAPK, Wnt, Rap1, TNF, adipocytokine, and leukocyte transendothelial migration which plays a significant role in immunomodulation, minimizing the oxidative stress and inflammation. Molecular docking and molecular dynamics simulation studies illustrated the potential of glycyrrhizic acid, amentoflavone, and mulberroside in inhibiting key SARS-CoV-2 proteins and these results could be exploited further in designing future ligands from natural sources.

During December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as a global pandemic originating from the Wuhan city of China, and still it is a major global threat due to high mortality and morbidity rates. The coronaviruses contain highly enveloped single stranded RNA with the genome size of 26-32-kilobases and requires the initial RNA synthesis, replication and transcription for its life cycle [1] [2] [3] . Two-thirds of the genome of all coronoviruses encodes pp1ab, a replicase polyprotein which comprises of two overlapping open reading frames (ORF1a and ORF1b), cleaved into 16 different non-structural proteins (NSPs) by viral proteases [4] . Amongst these NSPs, NSP-15 is ascribed with nidoviral uridylatespecific endoribonuclease (NendoU) activity involving uridylate-specific cleavage of RNAs.

NSP-15/NendoU activity is important in the innate immune responses and the viral life cycle [5] .

The structural protein protruding on viral surface called spike (S) glycoprotein which exist as a metastable prefusion homotrimeric form enables the entry of 2019-nCoV into the host cells through structural rearrangement. The binding of the S1 subunit of spike S glycoprotein to the angiotensin-converting enzyme 2 (ACE2) on the host cell leads to the transition of the S2 subunit to a highly stable post-fusion conformation which accelerates the viral entry process. Hence, the drugs targeting the viral proteases, nonstructural proteins and structural protein that block various stages of viral life cycle such as the entry, replication, and proliferation may exhibit a wide spectrum of activity [6] [7] [8] [9] .

The natural compounds, especially from plant resources, remained the choice in the lead identification programs due to their abundance, safety and broad spectrum of ensuing activities.

The flavonoids, bioflavonoids or polyphenolic compounds are a group of secondary metabolites present in fruits and vegetables and are well known for their health benefits. Flavonoids, a group of compounds containing flavan nucleus or a 15-carbon skeleton with two benezene rings linked through pyran ring, are well studied natural compounds comprising more than 6000 structurally well characterized molecules [10] . They are reported to possess health benefits in infectious, oncogenic, inflammatory and degenerative diseases [11] [12] [13] [14] . It is noteworthy that flavonoids have been extensively studied against the plethora of viruses to overcome the limitations of existing therapies [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . The recent in-silico studies have demonstrated the antiviral potential of natural compounds in COVID-19 [1] [2] [3] 28] .

Flavonoids have been proven to have a multidimensional therapeutic effect such as antiinflammatory, antiviral, antioxidant, cardioprotective, and have also shown their significant role in the treatment of respiratory associated problems, which are a key requirement for a drug to be effective against COVID-19 [1] [2] [3] 28] . In the present investigation, an attempt was made to evaluate the potency of some well-known bioflavonoids having multiple therapeutic properties against COVID-19, which can contribute to the scientific community exploring and identifying treatments for COVID-19. In the present investigation, molecular docking was performed on fifteen potential flavonoids derived from plants against three SARS CoV-2 proteins namely nonstructural protein-15 Endoribonuclease (NSP15), the receptor-binding domain of spike protein (RBD of S protein), and main protease (M pro , also called 3CL pro ) as targeted proteins. Further, the top ranking compounds on each protein were subjected to molecular dynamics simulation and Molecular Mechanics Poisson Boltzmann surface area continuum solvation (MM-PBSA) calculations to gain the deeper insights of binding affinity and possible mode of inhibition.

The molecular docking analysis of 15 bioflavonoids (Supplementary file) 

For the assessment of network pharmacology three major steps were performed: (a) prediction of bioactive targets, (b) enrichment analysis of regulated targets, and (c) construction of network between bioactives, targets, and pathways and its analysis. Briefly, targets of bioactives were predicted using DIGEP-Pred [37] at the pharmacological activity (Pa) of 0.5 and the modulated proteins were enriched using STRING [38] ver 11.0 for their cellular components, biological processes, molecular function, and KEGG (https://www.genome.jp/kegg/) pathway database. Similarly, the network between bioactives, their targets, and modulated pathways was constructed using Cytoscape [39] ver 3.5.1; any duplicates were removed and the whole network was analyzed based on edge count for color map and node size.

The biological spectrum of all the flavonoids was queried using PASS [40] at the pharmacological inactivity (Pi) and a complete dataset was constructed. Then a complete dataset was queried for the keyword "viral" to identify the probable anti-viral activities against multiple viruses.

The open reading frame 1ab (ORF1ab) located at 5' terminus of the SARS COV-2 genome encodes various non-structural proteins (NSP1-16) [41] . The NSP15 protein, a NendoU, is a monomer assemble into hexamer, generated by a dimer of trimers [42] . The crystal structure of NSP15 (PDB ID: 6W01) has been solved with the resolution of 1.90 Å and was found suitable for docking studies. Each monomer has 348 amino acid units and constitutes a catalytic Cterminal nidoviral RNA uridylate-specific endoribonuclease (NendoU) domain, a middle domain, and an N-terminal domain. However, 23 residues are missing in the crystal structure in each monomeric chain and these residues were modeled through the Prime module. The NendoU domain has the endoribonuclease activity which is responsible for cutting the double-stranded (ds) RNA substrates. The C-terminal catalytic domain comprises of two antiparallel β-sheets containing six key amino acids His235, His250, Lys290, Thr341, Tyr343, and Ser294 ( Figure 1 ).

The residues His235, His250, Lys290 form a catalytic triad where His235 serves as an acidic residue while His250 and Lys290 serve as a basic residue. The residues Ser294 and Tyr343

Another target protein explored in this computational study is the SARS-COV-2 spike RBD. SARS-CoV-2 uses this fusion spike glycoprotein to make entry into the host cells through the ACE-2 receptor [43, 44] . The spike glycoprotein has two subunits S1 and S2 which mediate attachment and membrane fusion respectively. The binding of the S1 subunit to the ACE-2 receptor results in the transition of the S2 subunit to a highly stable post-fusion conformation [45, 46] . The RBD S1 subunit has 5 twisted β sheets antiparallel to each other designated as β1, β2, β3, β4, and β7 sheets. The region between β4 and β7 strands has extended insertions of short β5 and β6 strands, α4 and α5 helices, and some loops. This extended insertion is called a receptor-binding motif (RBM) and it has most of the residues which bind to ACE-2 [43] . Our recent report [4] confirmed that the residues Lys417, Gly446, Tyr449, Tyr453, Leu455, Phe456, Ala475, Phe486, Asn487, Tyr489, Gln493, Gly496, Gln498, Thr500, Asn501, Gly502, Tyr505 are crucial for binding with N-terminal peptidase domain of ACE-2. However, from the cluster of these residues Gln493, Asn501, Tyr449, Tyr489, and Tyr505 could form the hydrogen bonding interaction, whereas Lys417 forms a salt bridge interaction.

The two overlapping poly-proteins (pp1a, pp1ab) encoded by ORF 1ab are cleaved into NSP1-16 by the main protease (M pro ) and the papain-like protease (PL pro ) [47] [48] [49] . Amongst these two proteases, M pro has gained much attention in drug development due to its key function in viral replication [47] . Numerous crystal structures of SARS-COV-2 M pro are available, amongst which the crystal structure (PDB ID: 6WNP) having the resolution 1.44 Å was found most suitable. This crystal structure also has a peptide inhibitor Boceprevir covalently bound to Cys145 residue at its binding site. The main protease forms a dimer of two protomers and each protomer has three domains i.e. domain I, II, and III comprising the residues 8-101, 102-184, and 185-306 respectively. The binding site is located at the cleft between domains I and II. The residues Cys145 and His41 form the catalytic dyad. The binding site has four pockets S1, S1', S2, and S4. The S1 pocket has the residues Phe140, Asn142, Glu166, His163, Leu141, and His172, while the adjacent S1' pocket is surrounded by hydrophobic residues Tyr24, Thr25, Thr26, and Leu27. The S2 pocket is surrounded by residues His41, Met49, Tyr54, Met165, and Asp187, while the S4 pocket is surrounded by residues Leu167, Phe185, and Gln192. Table 1 and supplementary file-Table S1 . In the case of SARS-COV-2 spike RBD, the docking scores for five top-ranked compounds from lower to higher values were in the order mulberroside < (R)-amygdalin < hesperidin < baicalin < orientin. This suggests the most favorable binding affinity of SARS-COV-2 spike RBD is for the compound mulberroside (Supplementary file- Table S2 ). The hydroxyl groups on the sugar moieties in mulberroside form hydrogen bonds with negatively charged Glu484 and Glu406 residues and positively charged Arg403 residue ( Figure 3 ). The central phenyl chalcone core accommodates in the hydrophobic pocket surrounded by residues Pro491, Leu492, Gln493, Tyr495, Tyr453, and Leu455. In the case of (R)-amygdalin, the phenyl ring forms π-cation interaction with positively charged Arg403 residue. Arg403 also forms a hydrogen bond with the glycosidic linkage oxygen atom. The hydroxyl groups on sugar moiety form hydrogen bonds J o u r n a l P r e -p r o o f with Lys417, Gln409, Glu406, and Tyr453 residues. The hydroxyl group on the phenyl ring in hesperidin forms a hydrogen bond with Gly496; while the hydroxyl groups on sugar moieties form a hydrogen bond with negatively charged Glu406, Asp420, and positively charged Lys417.

In the case of baicalin the phenyl ring substituted on chromone ring forms π-π stacking interaction with Tyr505; while the hydroxyl group on sugar moiety forms a hydrogen bond with and polar Asn142 at S1 pocket, while at S1' pocket it forms hydrogen bond interaction with Thr26 ( Figure 4 ). The 3,4 dihydroxyl groups on phenyl substituent form these hydrogen bonds at both S1 and S1' pockets with Asn142 and Thr26 residue. The hydroxyl groups on α-L- Remdesivir, on the other hand also occupies all the pockets, but it forms hydrogen bond interactions with S1 pocket residue Glu166 and S1' pocket residue Thr26. The phenyl ring substituted on phosphoramide forms a π-π stacking interaction with S2 pocket protonated residue His41. Amentoflavone forms hydrogen bond interactions with S1 pocket residue Glu166, S1' pocket residue Thr25, S2 pockets residues His41, and Ser46. It also forms a π-π stacking interaction with protonated His41 residue. Myricetin forms the hydrogen bond with Glu166 and Leu141 residues at S1 pocket and Arg188 residue at S2 pocket. Baicalein, with hydroxyl groups on the core chromone ring, form hydrogen bond interaction with S1 and S1' pocket residues Asn142, Gly143, and Thr26. Hesperidin, a close analog of rutin, forms a hydrogen bond with S1 pocket residues Asn142, Leu141, and Glu166. These results suggest that the flavonoid rutin has a better binding affinity due to interactions with key residues at all the pockets of the binding site of SARS-COV-2 main protease (M pro ).

J o u r n a l P r e -p r o o f The reference drug remdesivir forms hydrogen bonds with residues Gly248, His235, Lys290, Gln245, Tyr243, His250, and Gly247 with the longest lifetime. These results suggest that remdesivir could produce hydrogen bonds with many key residues at the binding site. It was also observed that the residues Lys290, Tyr343, and Gln245 are important in hydrogen bond formation.

In Figure S4 ). Interestingly, the residues from all the four pockets were found involved in such key hydrogen formation. Especially, the S1 pocket residues Glu166, Gly143 and Cys145, S1' pocket residues Leu27, Thr26, Thr25, S2 pocket residues Cys44, His41, Met165, and Met49 and S4 pocket residue Gln189 were found forming hydrogen bonds J o u r n a l P r e -p r o o f consistently. In the case of amentoflavone, these residues and S1 pocket residue His163 were found involved in hydrogen bond formation. Remdesivir forms hydrogen bonds with most of these residues and Thr190, His164, and Pro168 residues. These results suggest that the residues Glu166, His41, Gln189 are important in forming key hydrogen bond interactions.

MM-PBSA calculations carried out MD trajectories can provide more accurate estimates of binding affinity in terms of binding free energy. The g_mmpbsa program [35, 36] is useful in calculating the non-bonded interaction energies such as van der Waal energy, electrostatic energy, polar solvation energy, Solvent Accessible Surface Area (SASA) energy, and these energy values are used to calculate the binding free energy (ΔG binding ) (Supplementary file- Table   S4 ) Amentoflavone was found to have better lower binding free energy than the remdesivir. But only polar solvation energy contributions differ considerably in the final binding free energies.

A total of 199 targets were modulated by 15 flavonoids in which myricetin and scutellarein majorly targeted most regulated proteins i.e. 28 (Table 2) . Similarly, PLAU and TIMP1 proteins were mostly modulated by the maximum number of bio-actives i.e. 11 (Table 3) . J o u r n a l P r e -p r o o f 

Gene ontology analysis identified 565 biological processes in which response to hypoxia Apart from the anti-viral spectrum of the selected bio-actives against the novel coronavirus, the study also aimed to investigate the probable regulation of multiple proteins via the compounds. This is because, during COVID-19 infection, it has been proposed for the deregulation of nutrient and oxygen supply in the affected tissue leading to necrosis which could be the basic pathogenesis observed in autopsy [57] . This process is complex and involved the up-/down-regulation of multiple proteins and regulation of numerous pathways by affecting various cellular components, molecular functioning, and biological process which can be traced via the assessment of gene ontology enrichment analysis. Similarly, the present study enriched the bio-J o u r n a l P r e -p r o o f actives regulated proteins to evaluate their synergistic or additive probability for multiple pathways in regulating immunity, inflammation, and oxidative stress.

The risk of COVID-19 infection is reported to be more in subjects with co-morbid multiple infectious diseases (tuberculosis, malaria, HIV, etc) and non-infectious diseases (diabetes, obesity, cancer, etc) due to compromised immunity [58, 59] . Similarly, inflammation in the lungs and increased oxidative stress are also contributors to the progression of COVID-19

pathogenesis [60] . The selected bio-actives are the flavonoids, an important class of secondary metabolites with multiple beneficial values including immune booster, anti-inflammatory, and antioxidant activities. Hence, the present study utilized the GO analysis followed by network interaction of flavonoids to evaluate the above triplex action, which would be beneficial in the subjects with compromised immunity.

GO analysis identified the modulation of 565 biological processes in which response to hypoxia was majorly modulated. As explained previously, in COVID-19 infection, hypoxia in one of the major problems due to inadequate O 2 /CO 2 exchanges [61] . Hence, regulation of this pathway could be beneficial in ameliorating the exchange of gas and nutritional supply in infected cells/tissue and could synergist other biological processes like a response to stress and stimulus and minimize reactive oxygen species (ROS) system and inflammation. During drug action, efficacy may be affected via the change in effective concentration at the site of action or via the alteration of the rate of drug elimination [62] . Similarly, in the present study, the combined synergistic/additive also regulated the protein binding which would contribute to the regulation of pharmacokinetic/pharmacodynamic parameters. The previous report also reports the role of extracellular vesicles in viral infection and transmission [63] . In the present study also proteins from extracellular vesicles were predicted to be most affected which could get activated in response to novel coronavirus infection. Similarly, the present KEGG analysis identified the modulation of multiple signaling pathways like p53, FoxO, MAPK, Wnt, Rap1, TNF, Adipocytokine, and Leukocyte transendothelial migration that are involved in immune boost, minimizing the oxidative stress and inflammation [64] [65] [66] [67] [68] [69] [70] [71] . Further, the selected bio-actives were also identified to modulate the multiple pathways which are involved in the multiple infectious and non-infectious pathogenesis and would add a beneficial effect in treating the subjects suffering from the same.

Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and nonstructural protein-15: a pharmacoinformatics study

In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19

Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach

An insilico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets

Structural and Functional Analyses of the Severe Acute Respiratory Syndrome Coronavirus Endoribonuclease Nsp15

Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus

Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease

Drug for corona virus: A systematic review

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

Flavonoids: an overview

Biological Activities of Polyphenols from Grapes

Polyphenols as mitochondria-targeted anticancer drugs

Protective effects of flavonoids against microbes and toxins: The cases of hesperidin and hesperetin

Neuroprotective effects of chrysin: From chemistry to medicine

Plant-derived antiviral drugs as novel hepatitis B virus inhibitors: Cell culture and molecular docking study

Antiviral activity of selected flavonoids against Chikungunya virus

Antiviral activity of luteolin against Japanese encephalitis virus

Role of flavonoids in plant interactions with the environment and against human pathogens -A review

Therapeutic potential of flavonoids and their mechanism of action against microbial and viral infections-A review

Antiviral Natural Products for Arbovirus Infections

Antiviral Activities of Quercetin and Isoquercitrin Against Human Herpesviruses

Antiviral and Antimicrobial Assessment of Some Selected Flavonoids

Flavonoids: promising natural compounds against viral infections

Human cytomegalovirus-inhibitory flavonoids: Studies on antiviral activity and mechanism of action

Antiviral effect of flavonoids on human viruses

The role of andrographolide and its derivative in COVID-19 associated proteins and immune system

GROMACS: A message-passing parallel molecular dynamics implementation

Definition and testing of the GROMOS force-field versions 54A7 and 54B7

Validation of the GROMOS 54A7 Force Field with Respect to β-Peptide Folding

An Automated Force Field Topology Builder (ATB) and Repository: Version 1.0

Charge Group Partitioning in Biomolecular Simulation

Testing and validation of the Automated Topology Builder (ATB) version 2.0: prediction of hydration free enthalpies

Open Source Drug Discovery Consortium, A. Lynn, g_mmpbsa -A GROMACS Tool for High-Throughput MM-PBSA Calculations

Electrostatics of nanosystems: Application to microtubules and the ribosome

DIGEP-Pred: web service for in silico prediction of drug-induced gene expression profiles based on structural formula

The STRING database in 2017: J o u r n a l P r e -p r o o f quality-controlled protein-protein association networks, made broadly accessible

Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks

PASS Biological Activity Spectrum Predictions in the Enhanced Open NCI Database Browser

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China

Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

The SARS-CoV-2 main protease as drug target

Emerging coronaviruses: Genome structure, replication, and pathogenesis

Genomic characterization of a novel SARS-CoV-2

Comparing the Conformational Stability of Pyruvate Kinase in the Gas Phase and in Solution

Homol. Model

Molecular Dynamics Simulations of Peptides and Proteins with Amplified Collective Motions

The Role of Nonbonded Interactions in the Conformational Dynamics of Organophosphorous Hydrolase Adsorbed onto Functionalized Mesoporous Silica Surfaces

H-bonding in protein hydration revisited

PyContact: Rapid, Customizable, and Visual Analysis of Noncovalent Interactions in MD Simulations

Geometric criteria of hydrogen bonds in proteins and identification of `bifurcated' hydrogen bonds

Gross and histopathological pulmonary findings in a COVID-19 associated death during self-isolation

Innate Immune Recognition in Infectious and Noninfectious Diseases of the Lung

The Immune System and Infectious Diseases

Network pharmacology of AYUSH recommended immune-boosting medicinal plants against COVID-19

Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality

Effect of Binding to Plasma Proteins on the Distribution, Activity and Elimination of Drugs

The Role of Extracellular Vesicles in Viral Infection and Transmission

Emerging roles of p53 and other tumour-suppressor genes in immune regulation

FOXO transcription factors throughout T cell biology

Mitogen-activated protein kinases in innate immunity

Modulation of Inflammatory Responses by Wnt/β-Catenin Signaling in Dendritic Cells: A Novel Immunotherapy Target for Autoimmunity and Cancer

Ras family of small GTPases in immunity and inflammation

Immunomodulatory cytokines: directing and controlling immune activation

Getting Leukocytes to the Site of Inflammation

Mechanisms of Leukocyte Transendothelial Migration

J o u r n a l P r e -p r o o f